A new study underscores the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer. A test based on the detection...
A treatment for breast cancer-related vasomotor symptoms (VMS) – known as hot flashes – has seen positive Phase 3 trial results in women with breast cancer or...
The second annual Femtech World Awards will celebrate the very best of women’s health innovation, recognising individuals and organisations helping to transform outcomes around the world....
Researchers are using AI to enhance detection accuracy and efficiency, paving the way for a transformation in cervical cancer screening. With the aid of deep learning...
By Fard Johnmar health futurist, strategist, and co-founder of the FemAging Project
Leveraging new user insights, femble has announced a strategic pivot aimed at enhancing the doctor-patient relationship. Following the successful launch of its B2C app addressing cycle-related...
The distance between a patient’s home and an abortion-services facility where they would seek care significantly influences how they receive birth-control medications, according to a new...
Agentic AI platform Ema has raised US$3m to accelerate AI innovation in women’s health. Ema has been trained on a proprietary dataset of 10 million interactions...
The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women’s health innovation. We will be celebrating some...
By Morgan Rose, Chief Science Officer, Ema
